The US Food and Drug Administration (FDA) has approved Vetoquinol USA’s Imoxi Topical Solution for Cats.
In most places, the COVID vaccine rollout is confused at best. Vet med professionals share their vaccination frustrations and successes.
As states begin to authorize veterinarians to administer COVID vaccinations (should the need arise), some might ask, “What’s in it for me?” Potentially, a vaccination.
With mask restrictions now lifted in most US states and most states scheduled to be fully open with a few restrictions by July 4, many veterinary professionals are wondering what’s on the horizon as far as safety protocols.
The warning letter is only the latest step in a story that’s been unfolding since late last year when the company issued a voluntary pet food recall due to reports of possible aflatoxin contamination.
Xylitol-related calls to pet poison hotlines have skyrocketed in recent years. The Paws Off Act of 2021, which would require food products containing xylitol to include a warning label, could help.
The recent COVID-19 vaccine mandate, which has been temporarily blocked by a court injunction, would apply to an estimated 84 million US workers, including many in the veterinary field.
As the FDA’s new guidance about compounded drugs (GFI-256) goes into effect April 1, 2023, some substances could become harder to get or more expensive for clients. The FDA wants your input.
What does the human health crisis around xylazine mean for the future availability of this drug for veterinary use? Emily Singler, VMD, offers a snapshot of where we are currently in the race to regulate xylazine—and the potential impacts on vet med.
This week: Inaugural class at new veterinary school could get sent home come September, tracking baby turtles from the International Space Station, and would you like a lost-pet flyer with that pizza?